Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With Wyeth Merger In Beijing's Hands, Pfizer CEO Tours China To Launch Scholarly Partnerships

This article was originally published in The Pink Sheet Daily

Executive Summary

Just days after revealing that the Ministry of Commerce has delayed a decision on approval of the Pfizer-Wyeth merger, Kindler touched down in China to meet with government officials and launch the $1.5 million initiative.
Advertisement

Related Content

68 Billon Dollar Question: Could China's Government Block Worldwide Merger Of Wyeth And Pfizer?
68 Billon Dollar Question: Could China's Government Block Worldwide Merger Of Wyeth And Pfizer?
Global Pharma Giants Concered About China’s New Anti-Monopoly Law

Topics

Advertisement
UsernamePublicRestriction

Register

PS069774

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel